Back
Vanguard S&P Mid-Cap 400 Index Fund ETF Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
60
IVOO
Vanguard S&P Mid-Cap 400 Index Fund ETF
Last Price:
$114.01
Seasonality Move:
6%
Buy
67
GPCR
Structure Therapeutics, Inc.
Last Price:
$68.85
Seasonality Move:
-31.39%
Buy
60
Vanguard S&P Mid-Cap 400 Index Fund ETF (IVOO)
is a Buy
Is Vanguard S&P Mid-Cap 400 Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard S&P Mid-Cap 400 Index Fund ETF [IVOO] share price is $111.89. The Score for IVOO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
IVOO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $66.74. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IVOO Stock Price Chart
What is Vanguard S&P Mid-Cap 400 Index Fund ETF's stock price today?
-
The Vanguard S&P Mid-Cap 400 Index Fund ETF share price today is $111.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVOO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $66.74Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.
IVOO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 56.9 | Buy |
| Chaikin Money Flow: | -35715 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.4 | Buy |
| Relative Strength Index (14 RSI): | 80.52 | Buy |
| Chaikin Money Flow: | -2951117 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
IVOO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112 | Sell |
| 20-day SMA: | 110.01 | Buy |
| 50-day SMA: | 110.08 | Buy |
| 200-day SMA: | 105.21 | Buy |
| 8-day EMA: | 111.68 | Buy |
| 20-day EMA: | 110.74 | Buy |
| 50-day EMA: | 110.1 | Buy |
| 200-day EMA: | 107.24 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.28 | Buy |
| 20-day SMA: | 38.08 | Buy |
| 50-day SMA: | 32.93 | Buy |
| 200-day SMA: | 23.94 | Buy |
| 8-day EMA: | 47.33 | Buy |
| 20-day EMA: | 39.93 | Buy |
| 50-day EMA: | 33.93 | Buy |
| 200-day EMA: | 27.69 | Buy |
Vanguard S&P Mid-Cap 400 Index Fund ETF Earnings Growth & IVOO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.14 per share.
Vanguard S&P Mid-Cap 400 Index Fund ETF Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||